About

COMMITTED TO PREVENTING KIDNEY FAILURE
Collogh Cares Inc. is a digital health technology and advocacy start-up that is committed to “preventing kidney failure, one family at a time”. Headquartered in Montreal, Canada, we have developed a digital health therapeutic ecosystem specifically for patients with advanced Chronic Kidney Disease (pre-dialysis) – to facilitate remote monitoring, lifestyle modification, treatment adherence, and coordination of care.

Team

A world-class suite of engineers, nephrologists & global health professionals, tackling the kidney disease epidemic with a unique perspective.

Founding Team

Collins Oghor, MD, MBA
Chief Executive Officer
More
Paula Nwajei, MD
Chief Medical Officer
More
Justin Egwudo
Chief Technology Officer
More
Collins Nwalih
Chief Financial Officer
More
Mattias Paulsson
Chief Product Officer
More

Advisors

Diane Wish
Retired CEO at Centers for Dialysis Care
More
Carol Kim
Health Insurance Executive
More
Gihad Nesrallah, MD, MSc & MBA
Nephrologist & Epidemiologist
More

Partners

In addition to our support system of advisors, we have been accepted to the Fall 2021 cohort of Centech Propulsion – a 2-year Quebec government-supported world-class incubator which will provide us with office space, fundraising support, R&D support and mentorship on various aspects of building the company.

Next AI is a world-class program for artificial intelligence-based ventures and technology commercialization.

Co-founded by Hootesuite’s Ryan Holmes, League of Innovators (LOI) selects the most promising young entrepreneurs across Canada and provides them with resources to scale up their companies. We are honoured to be part of the 2022 cohort and continue to benefit greatly from LOI’s nationwide network of coaches, venture capitalists and fellow entrepreneurs.

We are also excited to be part of the new cohort of the 20 Most Promising Startups in Montreal. This will provide us with an increased network, access to multiple business opportunities, and exceptional talent and resources for our continued growth and development.

Investors

We are currently raising our pre-Seed round through a SAFE, targeting $1M USD. We are specifically seeking strategic investors who believe strongly in our mission and our approach to democratizing preventive care for marginalized patients.

Quarterly Investor Reports:

Q2 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Q1 2022

To book an investment enquiry session, fill out the form below:

Investment Inquiry